Search research articles
Contact Us
Filters
Showing results (1-10 of 8) with videos related to
Page
of 1
Sort By:
Molecular Cancer Therapeutics
|
July 15, 2004
Selenite-induced p53 Ser-15 phosphorylation and caspase-mediated apoptosis in LNCaP human prostate cancer cells
Cheng Jiang, Hongbo Hu, Barbara Malewicz, et al.
The Journal of Biological Chemistry
|
March 23, 2002
Sphingomyelin modulates the transbilayer distribution of galactosylceramide in phospholipid membranes
Peter Mattjus, Barbara Malewicz, Jacob T Valiyaveettil, et al.
Cancer
|
November 23, 2006
Augmented suppression of androgen receptor signaling by a combination of alpha-tocopheryl succinate and methylseleninic acid
Haitao Zhang, Yue Wu, Barbara Malewicz, et al.
Carcinogenesis
|
April 7, 2006
Enhancement of mammary carcinogenesis in two rodent models by silymarin dietary supplements
Barbara Malewicz, Zaisen Wang, Cheng Jiang, et al.
Biophysical Journal
|
January 18, 2005
The 3-hydroxy group and 4,5-trans double bond of sphingomyelin are essential for modulation of galactosylceramide transmembrane asymmetry
Barbara Malewicz, Jacob T Valiyaveettil, Kochurani Jacob, et al.
Molecular Cancer Therapeutics
|
May 14, 2004
Methyl selenium metabolites decrease prostate-specific antigen expression by inducing protein degradation and suppressing androgen-stimulated transcription
Sung Dae Cho, Cheng Jiang, Barbara Malewicz, et al.
Cancer Research
|
January 7, 2006
Potent antiandrogen and androgen receptor activities of an Angelica gigas-containing herbal formulation: identification of decursin as a novel and active compound with implications for prevention and treatment of prostate cancer
Cheng Jiang, Hyo-Jeong Lee, Guang-xun Li, et al.
Molecular Cancer Therapeutics
|
March 17, 2007
A novel class of pyranocoumarin anti-androgen receptor signaling compounds
Junming Guo, Cheng Jiang, Zhe Wang, et al.
Page
of 1
Search research articles
Search
Showing results (1-10 of 8) with videos related to
Sort By:
Page
of 1
Molecular Cancer Therapeutics
|
July 15, 2004
Selenite-induced p53 Ser-15 phosphorylation and caspase-mediated apoptosis in LNCaP human prostate cancer cells
Cheng Jiang, Hongbo Hu, Barbara Malewicz, et al.
The Journal of Biological Chemistry
|
March 23, 2002
Sphingomyelin modulates the transbilayer distribution of galactosylceramide in phospholipid membranes
Peter Mattjus, Barbara Malewicz, Jacob T Valiyaveettil, et al.
Cancer
|
November 23, 2006
Augmented suppression of androgen receptor signaling by a combination of alpha-tocopheryl succinate and methylseleninic acid
Haitao Zhang, Yue Wu, Barbara Malewicz, et al.
Carcinogenesis
|
April 7, 2006
Enhancement of mammary carcinogenesis in two rodent models by silymarin dietary supplements
Barbara Malewicz, Zaisen Wang, Cheng Jiang, et al.
Biophysical Journal
|
January 18, 2005
The 3-hydroxy group and 4,5-trans double bond of sphingomyelin are essential for modulation of galactosylceramide transmembrane asymmetry
Barbara Malewicz, Jacob T Valiyaveettil, Kochurani Jacob, et al.
Molecular Cancer Therapeutics
|
May 14, 2004
Methyl selenium metabolites decrease prostate-specific antigen expression by inducing protein degradation and suppressing androgen-stimulated transcription
Sung Dae Cho, Cheng Jiang, Barbara Malewicz, et al.
Cancer Research
|
January 7, 2006
Potent antiandrogen and androgen receptor activities of an Angelica gigas-containing herbal formulation: identification of decursin as a novel and active compound with implications for prevention and treatment of prostate cancer
Cheng Jiang, Hyo-Jeong Lee, Guang-xun Li, et al.
Molecular Cancer Therapeutics
|
March 17, 2007
A novel class of pyranocoumarin anti-androgen receptor signaling compounds
Junming Guo, Cheng Jiang, Zhe Wang, et al.
Page
of 1